BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15052614)

  • 1. Clinical evaluation and management of myasthenia gravis.
    Keesey JC
    Muscle Nerve; 2004 Apr; 29(4):484-505. PubMed ID: 15052614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenic antibodies in myasthenia gravis].
    Motomura M
    Brain Nerve; 2010 Apr; 62(4):411-8. PubMed ID: 20420182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
    Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
    Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenic syndromes.
    Farrugia ME
    J R Coll Physicians Edinb; 2011 Mar; 41(1):43-7; quiz 48. PubMed ID: 21365067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis and myasthenic syndromes.
    Engel AG
    Ann Neurol; 1984 Nov; 16(5):519-34. PubMed ID: 6095730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune myasthenia gravis.
    Gilhus NE
    Expert Rev Neurother; 2009 Mar; 9(3):351-8. PubMed ID: 19271944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
    Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
    Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired myasthenia gravis in childhood.
    Evoli A
    Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE; Stickler LL
    Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis: treatments and remissions].
    Dunand M; Lalive PH; Vokatch N; Kuntzer T
    Rev Med Suisse; 2007 May; 3(110):1185-6, 1188-90. PubMed ID: 17564346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.